HROW
Harrow Health, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +1.3% · netto nieuwe posities 0.0% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 80 | 0 | 11.44M | $485.62M | +8 | −8 |
| Q1 2026 | 83 | -4 | 11.18M | $394.57M | +6 | −10 |
| Q4 2025 | 87 | 0 | 11.51M | $563.95M | +1 | −1 |
| Q3 2025 | 15 | -1 | 7.56M | $364.09M | +1 | −2 |
| Q2 2025 | 13 | 0 | 7.79M | $237.82M | — | — |
| Q1 2025 | 10 | +1 | 3.25M | $86.47M | +1 | — |
| Q4 2024 | 9 | 0 | 2.94M | $98.57M | — | — |
| Q3 2024 | 8 | +1 | 2.10M | $94.28M | +2 | −1 |
| Q2 2024 | 7 | — | 1.47M | $30.78M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 2.57M | — | $78.35M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (passief) | 2.57M | — | $78.35M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (passief) | 2.57M | — | $78.35M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passief) | 2.57M | — | $78.35M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 2.57M | — | $78.35M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 2.57M | — | $78.35M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 2.57M | — | $78.35M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 2.57M | — | $78.35M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 2.57M | — | $78.35M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 2.57M | — | $78.35M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 2.57M | — | $78.35M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 2.57M | — | $78.35M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 2.57M | — | $78.35M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passief) | 2.57M | — | $78.35M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | The Vanguard Group ✦ (passief) | 1.87M | — | $57.09M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | The Vanguard Group ✦ (passief) | 1.87M | — | $57.09M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | The Vanguard Group ✦ (passief) | 1.87M | — | $57.09M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | The Vanguard Group ✦ (passief) | 1.87M | — | $57.09M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | The Vanguard Group ✦ (passief) | 1.87M | — | $57.09M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Geode Capital Management ✦ (passief) | 810.80K | +4.7% | $24.76M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 21 | Geode Capital Management ✦ (passief) | 810.80K | +4.7% | $24.76M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 22 | State Street Global Advisors ✦ (passief) | 773.11K | -1.7% | $23.61M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 23 | Citadel Advisors ✦ | 668.64K | +143.8% | $20.42M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 24 | Citadel Advisors ✦ | 668.64K | +143.8% | $20.42M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | Marshall Wace ✦ | 564.88K | +31.5% | $17.25M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 26 | Marshall Wace ✦ | 564.88K | +31.5% | $17.25M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 27 | D. E. Shaw & Co. ✦ | 208.18K | -55.5% | $6.36M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 28 | Renaissance Technologies ✦ | 142.52K | -41.9% | $4.35M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 29 | Wellington Management ✦ | 87.93K | +17.6% | $2.69M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | Wellington Management ✦ | 87.93K | +17.6% | $2.69M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 31 | Wellington Management ✦ | 87.93K | +17.6% | $2.69M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 32 | Wellington Management ✦ | 87.93K | +17.6% | $2.69M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 33 | Wellington Management ✦ | 87.93K | +17.6% | $2.69M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 34 | Millennium Management ✦ | 37.42K | -50.9% | $1.14M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 35 | Two Sigma Investments ✦ | 32.48K | -68.0% | $991,787 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 36 | T. Rowe Price ✦ | 22.81K | +12.4% | $697,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 37 | Fidelity (FMR) ✦ | 3.50K | — | $106,834 | 0.0% | n/c | 1 | SEC ↗ |
| 38 | Fidelity (FMR) ✦ | 3.50K | — | $106,834 | 0.0% | n/c | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 216 houders, 21.37M aandelen, $751.67M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 11.25K aand · $450,000
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie